Acadia Healthcare Company, Inc. (ACHC)

Over the past six months, Acadia Healthcare's stock has experienced a significant decline. Key events impacting the stock include the announcement of Fourth Quarter and Year-End 2024 Results, which led to a drop in share price due to diminished earnings and conservative guidance for 2025. Acadia reported first-quarter revenue of $770.5 million and reaffirmed its full-year 2025 guidance. Acadia Healthcare had a history of legal settlements, including a $179 million securities class action settlement, a $400 million settlement in October 2023 related to patient abuse allegations in New Mexico, and a $19.85 million settlement in September 2024 concerning allegations of medically unnecessary inpatient behavioral health services. Acadia Healthcare announced it would release its fourth quarter and year-end 2025 results on February 25, 2026, including an update to its professional and general liability reserves. Debbie Osteen was appointed as Chief Executive Officer.

Demand for Acadia Healthcare's products and services can be subject to seasonality, as evidenced by weaker-than-anticipated patient volumes in the first quarter of 2024, which the company attributed primarily to seasonality.

Acadia Healthcare Company, Inc. is a prominent American provider of for-profit behavioral healthcare services, operating within the Healthcare sector, specifically in the Psychiatric Hospitals and Mental Health & Substance Abuse Clinics industries. The company's services encompass a wide range of behavioral health and substance use disorder treatments, including acute inpatient psychiatric facilities, specialty treatment facilities, comprehensive treatment centers, residential treatment centers, and various outpatient behavioral healthcare services. The company's revenue is primarily derived from services provided to patients for inpatient psychiatric and substance abuse care, outpatient psychiatric care, and adolescent residential treatment.

Acadia Healthcare maintains a significant presence across the United States and Puerto Rico, operating a network of 262 to 278 behavioral healthcare facilities with approximately 11,850 to 12,500 beds in 39 to 40 states and Puerto Rico. Additionally, the company extends its geographic footprint to the United Kingdom through its subsidiary, Priory Group, which is a leading independent provider of behavioral care in the UK.

Acadia Healthcare's brand reputation in the past year has been affected by both positive recognition and significant legal challenges. The company has faced substantial legal settlements related to patient abuse allegations and claims of medically unnecessary inpatient behavioral health services, which have likely had a negative impact on its reputation. Seven of Acadia's facilities were recognized in Newsweek's 2024 list of America's Best Addiction Treatment Centers.

Acadia Healthcare Company, Inc. has a significant institutional ownership base, with 533 institutional owners and shareholders holding a total of 123,843,768 shares. Major institutional owners include BlackRock, Inc., Wellington Management Group Llp, and Vanguard Group Inc. Individual insiders hold approximately 1.45% of the shares. Khrom Capital Management LLC has been noted for significant insider buying in the past year.